RENALYTIX PLC
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$2.35M
Revenue
$-28.03M
Net Income
-0.25
EPS (Diluted)
$-51.37M
Free Cash Flow
Profitability
Gross Margin
12.71%
Operating Margin
-1054.93%
Net Profit Margin
-1191.75%
EBITDA
$-24.15M
Returns & Efficiency
Return on Assets (ROA)
-584.69%
Return on Equity (ROE)
-
Gross Profit
$299.00K
Operating Income
$-24.81M
Financial Health
Total Assets
$4.79M
Total Debt
-
Debt to Equity
-x
Current Ratio
0.24
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-0.25
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
FINSGATE
5-7 CRANWOOD STREET LONDON, None EC1V 9EE |
| Phone | 44 29 2071 0570 |
| Incorporated | DE, US |
| EIN | 000000000 |
| Fiscal Year End | 0630 |
| Shares Outstanding | 105.70M |
| Stockholders' Equity | $-11.32M |
| Cash & Equivalents | $909.00K |
Recent Filings
View All
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-11-25
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-10-11
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-09-30
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-03-29
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2023-11-13
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
12.7%
Operating Margin
-1054.9%
Net Margin
-1191.8%
ROE
-
ROA
-584.7%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
0.24
Total Debt
-
Total Assets
$4.79M
Stockholders' Equity
$-11.32M
Income Statement (FY 2024)
Revenue
$2.35M
Gross Profit
$299.00K
Operating Income
$-24.81M
Net Income
$-28.03M
EPS (Diluted)
$-0.25
Cash Flow (FY 2024)
Free Cash Flow
$-51.37M
Cash & Equivalents
$909.00K
Revenue Growth
2.8%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...